Global Stock Today

CO -  USA Stock  

USD 5.26  0.07  1.35%

Global Cord is selling for 5.26 as of the 25th of July 2021. This is a 1.35 percent up since the beginning of the trading day. The stock's open price was 5.19. Global Cord has about a 44 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Global Cord Blood are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of April 2021 and ending today, the 25th of July 2021. Click here to learn more.
 Market Performance
6 of 100
  Odds Of Distress
Less than 44

Global Cord Stock Profile

The upcoming quarterly report is expected on the 23rd of August 2021. Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the Peoples Republic of China. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 1260 people. more on Global Cord
Global Cord Blood was previously known as Global Cord Blood and was traded on New York Stock Exchange under the symbol CNDZF.
Global Cord Blood has a poor financial position based on the latest SEC disclosures
About 71.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Purchase by Mccarthy Kent C of 50000 shares of Global Cord
Global Cord Fama & French Healthcare
Fama & French Classification
Global Cord Blood SEC Filings
Global Cord SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameGlobal Cord Blood
Older SymbolCNDZF
CEO of Beijing DivisionYue Deng  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
Average Analyst Recommendation
Analysts covering Global Cord report their recommendations after researching Global Cord's financial statements, talking to executives and customers, or listening in on Global Cord's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Global Cord Blood. The Global consensus assessment is calculated by taking the average forecast from all of the analysts covering Global Cord.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Global Cord Blood based on its profitability, leverage, liquidity, source of funds, and operating efficiency. it is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Global Cord Blood financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 4 - PoorDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares124.4 M139.8 M
Fairly Down
Slightly volatile
Net Cash Flow from Operations707.3 M717.6 M
Fairly Down
Slightly volatile
Total Assets6.9 B8.3 B
Significantly Down
Slightly volatile
Total Liabilities3.4 B3.8 B
Fairly Down
Slightly volatile
Current Assets5.2 B6.5 B
Significantly Down
Slightly volatile
Current Liabilities642.7 M656.4 M
Fairly Down
Slightly volatile
Total Debt4.1 MM
Fairly Up
Slightly volatile
Return on Average Assets0.0510.0603
Fairly Down
Very volatile
Gross Margin0.970.97
Slightly volatile
Asset Turnover0.160.16
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Global Cord's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Global Cord's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Global Cord's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Global Cord's financial leverage. It provides some insight into what part of Global Cord's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Global Cord's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Global Cord deploys its capital and how much of that capital is borrowed.
Global Cord cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 3.31 M of total liabilities. Global Cord Blood has a current ratio of 10.12, indicating that it is in good position to pay out its debt commitments in time.

Operating Cash Flow

707.31 MillionShare
Global Cord Blood (CO) is traded on New York Stock Exchange in USA. It is located in Bank of China Tower and employs 1,260 people. Global Cord Blood was previously known as Global Cord Blood and was traded on New York Stock Exchange under the symbol CNDZF. Global Cord is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with market capitalization of 639.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Global Cord's market, we take the total number of its shares issued and multiply it by Global Cord's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Global Cord Blood is active under Healthcare sector as part of Diagnostics & Research industry. The entity has 121.55 M outstanding shares of which 769.73 K shares are currently sold short in the market by investors with about 4.9 days to cover all shorted shares. Global Cord Blood reports about 5.87 B in cash with 45.05 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 48.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Global Cord Probability Of Bankruptcy
Global Cord secures a total of 121.55 Million outstanding shares. Global Cord retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 71.43 (percent) of Global Cord outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Global Ownership Details

Global Stock Price Odds Analysis

What are Global Cord's target price odds to finish over the current price? Proceeding from a normal probability distribution, the odds of Global Cord jumping above the current price in 90 days from now is about 59.61%. The Global Cord Blood probability density function shows the probability of Global Cord stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon Global Cord has a beta of 0.8101 suggesting as returns on the market go up, Global Cord average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Global Cord Blood will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1317, implying that it can generate a 0.13 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 5.26HorizonTargetOdds Up 5.26 
40.21%90 days
Based on a normal probability distribution, the odds of Global Cord to move above the current price in 90 days from now is about 59.61 (This Global Cord Blood probability density function shows the probability of Global Stock to fall within a particular range of prices over 90 days) .

Global Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Global Cord that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Global Cord's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Global Cord's value.
InstituionSecurity TypeTotal SharesValue
Mosaic Family Wealth LlcCommon Shares12.3 K66 K
Graveslight Private Wealth Management IncCommon Shares600K
Group One Trading LpCall Options15.5 K702 K
View Global Cord Diagnostics

Global Cord Historical Income Statement

Global Cord Blood Income Statement is one of the three primary financial statements used for reporting Global's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Global Cord Blood revenue and expense. Global Cord Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Global Cord Operating Income is quite stable at the moment as compared to the past year. The company's current value of Operating Income is estimated at 693.64 Million. Income Tax Expense is expected to rise to about 125.4 M this year, although the value of Cost of Revenue will most likely fall to about 192.7 M. View More Fundamentals

Global Stock Against Markets

Picking the right benchmark for Global Cord stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Global Cord stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Global Cord is critical whether you are bullish or bearish towards Global Cord Blood at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Global Cord without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now


Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Global Cord Corporate Directors

Global Cord corporate directors refer to members of a Global Cord board of directors. The board of directors generally takes responsibility for the Global Cord's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Global Cord's board members must vote for the resolution. The Global Cord board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mark Chen - Non-Executive Independent DirectorProfile
Ken Lu - Non-Executive Independent DirectorProfile
Jennifer Weng - Non-Executive Independent DirectorProfile
Albert Chen - Chief Financial Officer, DirectorProfile
Continue to Trending Equities. Note that the Global Cord Blood information on this page should be used as a complementary analysis to other Global Cord's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Global Stock analysis

When running Global Cord Blood price analysis, check to measure Global Cord's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Cord is operating at the current time. Most of Global Cord's value examination focuses on studying past and present price action to predict the probability of Global Cord's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Global Cord's price. Additionally, you may evaluate how the addition of Global Cord to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
The market value of Global Cord Blood is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Cord's value that differs from its market value or its book value, called intrinsic value, which is Global Cord's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Cord's market value can be influenced by many factors that don't directly affect Global Cord Blood underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Cord's value and its price as these two are different measures arrived at by different means. Investors typically determine Global Cord value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Cord's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.